3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Multiple Myeloma
2
Patient Compliance
1
Pain
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Clodronic Acid
×
Clear all
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled